[
    {
        "question": "Mechanism of action of Temozolomide is :",
        "exp": "Temozolomide is an alkylating agent . It is the drug of choice for brain tumors.Other alkylating agents are:* If: Ifosfamide* Bus: Busulfan* Not: Nitrosoureas* Present: Procarbazine* Take: Temozolamide* My: Mephalan, Mechlorethamaide* Cycle: CyclophosphamideTopoisomerase inhibitor is Etoposide.Microtubule inhibitors are Vincristin, Vinblastin.Proteosome inhibitors are Boezomib.",
        "cop": 1,
        "opa": "Alkylation of DNA",
        "opb": "Inhibition of topoisomerase",
        "opc": "Microtubule inhibition",
        "opd": "Proteasome inhibition",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2018",
        "id": "53f16396-72ef-4b4f-82c1-f6b3a50d8044",
        "choice_type": "single"
    },
    {
        "question": "Axicabtagene ciloleucel is used in:",
        "exp": "CAR T-cell therapy:- A type of treatment in which a patients T cell are changed in laboratory so they will bind to cancer cells and kill them.Blood from a vein in Patient's arm flow through a tube to an apheresis machine, which removes the T cell and sends rest of blood back to the patient. CAR T cell are grown in the lab. The CAR T cell are able to bind to antigen on cancer cell and kill them. There are 2 FDA approved CAR T cell therapies:- Axicabtagene ciloleucel- Tisagenlecleucel Axicabtagene ciloleucel is use for diffuse large B cell lymphoma",
        "cop": 3,
        "opa": "Relapsed myeloma",
        "opb": "T cell lymphoma",
        "opc": "Diffuse large B cell lymphoma",
        "opd": "Small cell lung Ca",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2018",
        "id": "ecb9eb7e-14f9-4468-944b-ddf468e0af5a",
        "choice_type": "multi"
    },
    {
        "question": "All adverse effects of theophylline are mediated by adenosine A1, receptor antagonism except:",
        "exp": "Theophylline cause bronchodilation 2 mechanism:(1) PDE inhibition(2) Adenosine A1 antagonism Adverse effect of Theophylline Mechanism Nausea and vomiting PDE inhibition Headache PDE inhibition Gastric discomfo PDE inhibition Diuresis Adenosine A1 antagonism Arrythmias PDE inhibition, Adenosine A1 antagonism Seizures Adenosine A1 antagonism",
        "cop": 4,
        "opa": "Cardiac arrhythmias",
        "opb": "Diuresis",
        "opc": "Seizures",
        "opd": "GI discomfo",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2018",
        "id": "a03f0a98-d72d-4bd2-a4f1-b094d44d27db",
        "choice_type": "multi"
    },
    {
        "question": "Which of the following statement is false about drugs used in rheumatoid ahritis?",
        "exp": "Drug ending with inib - JAK inhibitor and given orally.- Tofacitinib- Beracitinib Drug ending with Mab: - Monoclonal antibody and IL-6 inhibitor.- Tocilizumab- SarilumabSix : IL-6A-AhritisR-RheumatoidI - InterleukinL - InterleukinUMAB: Monoclonal Antibody.All above mentioned drugs are used for Rheumatoid ahritis. Tocilizumab: is also use for cytokine release syndrome.",
        "cop": 3,
        "opa": "Tofacitinib inhibits JAK1 and JAK3",
        "opb": "Tocilizumab inhibits IL-6",
        "opc": "Tofactinib is given intravenously",
        "opd": "Tocilizumab is given by intravenous and subcutaneous route",
        "subject_name": "Pharmacology",
        "topic_name": "JIPMER 2018",
        "id": "1afbf66c-4ffb-44ff-a058-2fe1f44b9698",
        "choice_type": "multi"
    }
]